Home >> Signaling Pathways >> GPCR/G protein >> Cannabinoid Receptor

Cannabinoid Receptor

The cannabinoid receptor (CB1 and CB2) is a member of G-protein coupled receptor which plays a significant role in physiologic processes such as cognitive and immune functions.

Products for  Cannabinoid Receptor

  1. Cat.No. Product Name Information
  2. GC10907 (±)-SLV 319 (±)-SLV 319 ((±)-SLV319) is the racemate of SLV319. (±)-SLV 319  Chemical Structure
  3. GC10028 (R)-SLV 319 CB1 receptor antagonist (R)-SLV 319  Chemical Structure
  4. GC63410 (Rac)-MRI-1867 (Rac)-MRI-1867 ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-MRI-1867  Chemical Structure
  5. GC10753 (S)-SLV 319 (S)-SLV 319 (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. (S)-SLV 319  Chemical Structure
  6. GC16403 2-Arachidonoyl Glycerol

    An endogenous agonist of the cannabinoid (CB) receptors CB1 and CB2

    2-Arachidonoyl Glycerol  Chemical Structure
  7. GC16196 2-Palmitoylglycerol Endogenous fatty acid glycerol ester 2-Palmitoylglycerol  Chemical Structure
  8. GC17100 4-Quinolone-3-Carboxamide CB2 Ligand ligand of the CB2 receptor 4-Quinolone-3-Carboxamide CB2 Ligand  Chemical Structure
  9. GC15850 4-Quinolone-3-Carboxamide Furan CB2 Agonist 4-Quinolone-3-Carboxamide Furan CB2 Agonist is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor with a Ki of 8.5 nM. 4-Quinolone-3-Carboxamide Furan CB2 Agonist  Chemical Structure
  10. GC18199 A-836339 A-836339 is a synthetic cannabinoid (CB) which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 receptor (Ki = 270 nM). A-836339  Chemical Structure
  11. GC16480 AM 281 A CB1 antagonist AM 281  Chemical Structure
  12. GC62835 AM-6538 AM6538 is a long-acting, high affinity and pseudo-irreversible cannabinoid (CB) antagonist. AM-6538  Chemical Structure
  13. GC15414 AM1241 Cannabinoid CB2 receptor agonist,potent and selective AM1241  Chemical Structure
  14. GC15717 AM251

    A potent CB1 antagonist

    AM251  Chemical Structure
  15. GC15093 AM4113 AM4113 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM. AM4113  Chemical Structure
  16. GC10147 AM630

    An inverse agonist at CB2 and partial agonist at CB1 receptors

    AM630  Chemical Structure
  17. GC14661 AM6545 CB1 selective neutral antagonist AM6545  Chemical Structure
  18. GC35339 Anandamide An immune modulator in the central nervous system Anandamide  Chemical Structure
  19. GC18435 Arachidonoyl 2'-Chloroethylamide A potent and selective CB1 receptor agonist Arachidonoyl 2'-Chloroethylamide  Chemical Structure
  20. GC16826 Arachidonoyl amide CB1 receptor agonist Arachidonoyl amide  Chemical Structure
  21. GC18097 Arachidonoyl Serinol CB1 receptor agonist Arachidonoyl Serinol  Chemical Structure
  22. GC11849 Arachidonyl serotonin Arachidonyl serotonin (Arachidonyl serotonin; AA-5-HT) is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 value of 1~12 μM. Arachidonyl serotonin  Chemical Structure
  23. GC10205 Arvanil Cannabinoid CB1 and vanilloid TRPV1 (VR1) agonist Arvanil  Chemical Structure
  24. GC14115 AVE-1625 AVE-1625 (AVE1625) is an orally active CB1 receptor antagonist. AVE-1625  Chemical Structure
  25. GC62855 AZD1940 AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively. AZD1940  Chemical Structure
  26. GC61778 BAY 38-7271 BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist, with Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 receptor, respectively. BAY 38-7271  Chemical Structure
  27. GC19060 Bay 59-3074 Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively . Bay 59-3074  Chemical Structure
  28. GC11376 BML-190 CB2 receptor ligand BML-190  Chemical Structure
  29. GC66030 CB1 agonist 1 CB1 agonist 1 (compound 22) is an agonist of CB1. CB1 agonist 1 shows affinity to CB1 receptor with an pIC50 value of 5.7. CB1 agonist 1 can be used for the research of brain disorders. CB1 agonist 1  Chemical Structure
  30. GC31306 CB1 antagonist 1 CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions. CB1 antagonist 1  Chemical Structure
  31. GC30935 CB1-IN-1 CB1-IN-1 (BPRCB1184) is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively. CB1-IN-1  Chemical Structure
  32. GC33756 CB2R-IN-1 CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 0.9 nM. CB2R-IN-1  Chemical Structure
  33. GC18110 COR 170 inverse agonist of CB2 receptors COR 170  Chemical Structure
  34. GC17205 CP-945598 HCl CP-945598 HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. CP-945598 HCl  Chemical Structure
  35. GC50579 Ec2la Ec2la is an orally active cannabinoid type-2 receptors (CB2Rs) positive allosteric modulator. Ec2la  Chemical Structure
  36. GC11760 GW842166X Cannabinoid receptor agonist GW842166X  Chemical Structure
  37. GC17133 Hemopressin (human, mouse) CB1 receptor inverse agonist; endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE Hemopressin (human, mouse)  Chemical Structure
  38. GC17116 Hemopressin (rat) selective CB1 receptor inverse agonist Hemopressin (rat)  Chemical Structure
  39. GC13965 HU 308

    CB2-receptor agonist

    HU 308  Chemical Structure
  40. GC13660 JD5037 inverse agonist at CB1 receptors JD5037  Chemical Structure
  41. GC16644 JTE 907 cannabinoid CB2 receptor inverse agonist JTE 907  Chemical Structure
  42. GC10885 JWH 133 An Analytical Reference Standard JWH 133  Chemical Structure
  43. GC18496 Leelamine (hydrochloride) Leelamine is a diterpene molecule whose name derives from the Sanskrit word leela which means 'play'- It has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 uM. Leelamine (hydrochloride)  Chemical Structure
  44. GC50273 LEI 101 hydrochloride Potent and selective CB2 partial agonist; orally biovailable LEI 101 hydrochloride  Chemical Structure
  45. GC12538 LH 21 silent CB1 antagonist LH 21  Chemical Structure
  46. GC13318 LY 320135 CB1 receptor antagonist/inverse agonist LY 320135  Chemical Structure
  47. GC19231 LY2828360 LY2828360 is a slowly acting but efficacious G protein-biased cannabinoid (CB2) agonist, inhibiting cAMP accumulation and activating ERK1/2 signaling. LY2828360  Chemical Structure
  48. GC12420 MAFP

    cPLA2 and iPLA2 inhibitor, potent FAAH inhibitor

    MAFP  Chemical Structure
  49. GC36579 MDA 19 MDA 19  Chemical Structure
  50. GC15788 MJ 15 CB1 receptor antagonist MJ 15  Chemical Structure
  51. GC11453 ML-191 inhibitor of LPI-induced phosphorylation of ERK1/2 ML-191  Chemical Structure
  52. GC14626 MM-22

    biotinylated anandamide analog acts as a probe for visualizing the accumulation and intracellular trafficking of anandamide

    MM-22  Chemical Structure
  53. GC14750 N-Arachidonylglycine

    Endogenous anandamide-like compound

    N-Arachidonylglycine  Chemical Structure
  54. GC31536 N-Oleoyl glycine

    A putative substrate for peptidyl glycine αamidating enzyme

    N-Oleoyl glycine  Chemical Structure
  55. GC18041 NESS 0327 extremely potent cannabinoid (CB) receptor antagonist NESS 0327  Chemical Structure
  56. GC13267 NIDA 41020 CB1 receptor antagonist NIDA 41020  Chemical Structure
  57. GC69562 Nimacimab

    Nimacimab (RYI-018) is a negative allosteric modulating monoclonal antibody that targets the CB1 receptor. Nimacimab can be used in research on metabolic diseases.

    Nimacimab  Chemical Structure
  58. GC17699 O-1821

    cannabidiol analog with close structural similarity to O-1918 which is a selective antagonist of abnormal cannabidiol

    O-1821  Chemical Structure
  59. GC13847 O-1918

    endothelial anandamide receptor antagonist

    O-1918  Chemical Structure
  60. GC16651 O-2050 high affinity cannabinoid CB1 receptor silent antagonist O-2050  Chemical Structure
  61. GC14042 Oleamide CB1 cannabinoid receptor agonist Oleamide  Chemical Structure
  62. GC30966 Olivetol Olivetol is a naturally phenol found in lichens and produced by certain insects, acting as a competitive inhibitor of the cannabinoid receptors CB1 and CB2. Olivetol  Chemical Structure
  63. GC30504 Olorinab (APD 371) Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist, with an EC50 of 6.2 nM for hCB2. Olorinab (APD 371)  Chemical Structure
  64. GC10664 Org 27569 Cannabinoid CB1 receptor allosteric modulator Org 27569  Chemical Structure
  65. GC10843 Otenabant Otenabant  Chemical Structure
  66. GC16548 Palmitoylisopropylamide FAAH inhibitor Palmitoylisopropylamide  Chemical Structure
  67. GC14461 PB-22 Synthetic cannabinoid PB-22  Chemical Structure
  68. GC16171 PF 514273 CB1 receptor antagonist PF 514273  Chemical Structure
  69. GC50387 PM 226 Potent and selective CB2 receptor agonist; BBB permeable; neuroprotective PM 226  Chemical Structure
  70. GC12920 Pregnenolone steroid hormone Pregnenolone  Chemical Structure
  71. GC36963 Pregnenolone monosulfate Pregnenolone monosulfate (3β-Hydroxy-5-pregnen-20-one monosulfate) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone monosulfate  Chemical Structure
  72. GC44680 Pregnenolone sulfate (sodium salt) Pregnenolone sulfate (sodium salt) (3β-Hydroxy-5-pregnen-20-one monosulfate sodium) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone sulfate (sodium salt)  Chemical Structure
  73. GC65106 Pregnenolone-d4-1 Pregnenolone-d4-1  Chemical Structure
  74. GC50435 PSB CB5 Selective GPR18 antagonist PSB CB5  Chemical Structure
  75. GC50143 PSNCBAM-1 Negative allosteric modulator of CB1 receptors PSNCBAM-1  Chemical Structure
  76. GC14177 R-1 Methanandamide Phosphate CB1 receptor agonist R-1 Methanandamide Phosphate  Chemical Structure
  77. GC13190 R-Palmitoyl-(1-methyl) Ethanolamide synthetic analog of palmitoyl ethanolamide (PEA) R-Palmitoyl-(1-methyl) Ethanolamide  Chemical Structure
  78. GC17259 Rimonabant CB1 receptor antagonist Rimonabant  Chemical Structure
  79. GC16466 Rimonabant hydrochloride A potent and selective CB1 receptor antagonist Rimonabant hydrochloride  Chemical Structure
  80. GC63617 RTICBM-189 RTICBM-189 is a potent, brain-penetrant allosteric modulator of the cannabinoid type-1 (CB1) receptor with a pIC50 of 7.54 in Ca2+ mobilization assay. RTICBM-189  Chemical Structure
  81. GC66413 RVD-Hpα TFA RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. RVD-Hpα TFA increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. RVD-Hpα TFA also high affinity CB2 positive allosteric modulator (Ki=50 nM). RVD-Hpα TFA  Chemical Structure
  82. GC13605 S-1 Methanandamide CB1 receptor ligand S-1 Methanandamide  Chemical Structure
  83. GC12868 S-2 Methanandamide potent CB1 receptor agonist S-2 Methanandamide  Chemical Structure
  84. GC67972 S-777469 S-777469  Chemical Structure
  85. GC50271 SCH 336 Highly potent and selective CB2 inverse agonist SCH 336  Chemical Structure
  86. GC10032 SR 144528 CB2 receptor inverse agonist SR 144528  Chemical Structure
  87. GC15574 Taranabant A CB1 receptor inverse agonist Taranabant  Chemical Structure
  88. GC37737 Taranabant ((1R,2R)stereoisomer) Taranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant. Taranabant ((1R,2R)stereoisomer)  Chemical Structure
  89. GC37738 Taranabant racemate Taranabant racemate (MK-0364 racemate) is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1. Taranabant racemate  Chemical Structure
  90. GC10646 TC-C 14G CB1 receptor inverse agonist TC-C 14G  Chemical Structure
  91. GC65277 Tedalinab Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab  Chemical Structure
  92. GC15327 Tetrahydromagnolol peripheral CB2 receptor agonist Tetrahydromagnolol  Chemical Structure
  93. GC39666 TM38837 TM38837 is a peripheral selective cannabinoid receptor type 1 (CB1) receptor antagonist. TM38837  Chemical Structure
  94. GC12978 Tocrifluor T1117 Tocrifluor T1117 (T1117), a fluorescent form of the cannabinoid CB1 receptor antagonist AM251, is a selective fluorescent GPR55 ligand. Tocrifluor T1117  Chemical Structure
  95. GC37889 VCE-004.8 VCE-004.8 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. VCE-004.8  Chemical Structure
  96. GC70118 Vicasinabin

    Vicasinabin (RG7774) is an effective agonist of the cannabinoid receptor 2 (CB2). Vicasinabin has potential for researching human diseases, including chronic pain, atherosclerosis, bone regulation, neuroinflammation and other related conditions (information extracted from patent US20130116236A1).

    Vicasinabin  Chemical Structure
  97. GC45150 Voacamine Voacamine is an alkaloid originally isolated from Voacanga that has diverse biological activities. Voacamine  Chemical Structure
  98. GC37935 WIN 55,212-2 Mesylate A potent CB1 and CB2 receptor agonist WIN 55,212-2 Mesylate  Chemical Structure
  99. GC31809 Yangonin An Analytical Reference Standard Yangonin  Chemical Structure
  100. GC33681 β-Caryophyllene β-Caryophyllene is a CB2 receptor agonist. β-Caryophyllene  Chemical Structure

99 Item(s)

per page

Set Descending Direction